 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer
|
|
|
|
Phase II, Phase I
|
|
|
|
UCIRB #14735B
GV-001.010 (TNF-ELF), NCT00496236
|
|
| |
Fruit and Vegetable Extracts in Treating Patients With Stage I, Stage II, Stage III, Stage IVA, or Stage IVB Head and Neck Cancer
|
|
|
|
Phase II
|
|
|
|
CCCWFU-0112
CCCWFU-60A02, CCCWFU-BG03-161, NCT00064298
|
|
| |
Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer
|
|
|
|
Phase II
|
|
|
|
06U.195
NCT00358007
|
|
| |
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
|
|
|
|
Phase II
|
|
|
|
SCCC-2002103
SCCC-02/618C, SCCC-20050715, SCCC-20020618, NCT00453336
|
|
| |
Sorafenib Plus Carboplatin and Paclitaxel in Head and Neck Squamous Cell Cancer
|
|
|
|
Phase II
|
|
|
|
2006-0940
NCT00494182
|
|
| |
UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
|
|
|
|
Phase II
|
|
|
|
F070824015
UAB 0718, NCT00570232
|
|
| |
Phase II Trial Evaluating Elimination of Radiation Therapy
|
|
|
|
Phase II
|
|
|
|
07-0142
NCT00593840
|
|
| |
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
|
|
|
|
Phase II
|
|
|
|
08-050
NCT00713219
|
|
| |
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
|
|
|
|
Phase I
|
|
|
|
05C.255
NCT00329589
|
|
| |
Vaccine Therapy in Treating Patients With Head and Neck Cancer
|
|
|
|
Phase I
|
|
|
|
PCI-03-156
PCI-0507062, NCT00404339
|
|
